Posts Tagged ‘end-stage renal disease’

Polycystic Kidney Disease

Posted by Carla Rothaus • December 11th, 2014

In patients with autosomal dominant polycystic kidney disease, the rate of increase in total kidney volume was not slowed by lisinopril and telmisartan, as compared with lisinopril and placebo, but was slowed with rigorous blood-pressure control. Autosomal dominant polycystic kidney disease (ADPKD) is characterized by gradual cyst enlargement over a period of decades before the… Read More…

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Posted by Daniela Lamas • December 26th, 2013

Intuitively, controlling diabetic kidney disease should be easy – manage hyperglycemia, manage blood pressure. And the more control, the better, right? Unfortunately, it hasn’t been so simple. With effective treatment of hyperglycemia and control of blood pressure, the incidence of end-stage renal disease (ESRD) due to diabetes has reached a plateau in the past 10… Read More…

IgA Nephropathy

Posted by Sara Fazio • June 21st, 2013

IgA nephropathy is a common glomerular disease that is an important cause of kidney failure. The latest review in our Medical Progress series discusses advances in the therapy and understanding of the molecular basis of IgA nephropathy, a common glomerulopathy that not infrequently leads to kidney failure. IgA nephropathy is the most prevalent primary chronic… Read More…

Abdominal Pain after Peritoneal Dialysis

Posted by Sara Fazio • January 25th, 2013

In the latest Case Record of the Massachusetts General Hospital, a 72-year-old woman with end-stage renal disease (ESRD) was admitted to the hospital because of nausea, vomiting, and abdominal pain and distention. The patient had been receiving continuous ambulatory peritoneal dialysis for 18 months for ESRD presumed to be due to diabetic nephropathy Patients undergoing… Read More…

FSGS

Posted by Sara Fazio • December 23rd, 2011

A new review in our Medical Progress series, “Focal Segmental Glomerulosclerosis,” comes from Vivette ’Agati, M.D., at Columbia University College of Physicians and Surgeons, Frederick Kaskel, M.D., Ph.D., at Albert Einstein College of Medicine, and Ronald Falk, M.D., and the University of North Carolina, Chapel Hill. Focal segmental glomerulosclerosis accounts for approximately 20% of cases… Read More…